Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemiralisib in Acute Exacerbation of COPD
NCT02294734Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of nemiralisib in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Mar 2015; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02294734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294734.